Targeted therapy to treat acute myelogenous leukaemia (AML) may be closer, thanks to recent research. The scientists discovered that inhibition of Leo1 and Leo1 downstream signalling pathways provide ...

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood. About 15% of leukemias ...

You have full access to this article via your institution. In 2005, investigators in Melbourne, Victoria, Australia found a five-fold increase in the hazard ratio (HR) for myeloid leukemias (acute and ...

Those with symptoms of leukemia or Chronic Myelogenous Leukemia (CML) are further investigated to confirm the diagnosis of CML and commence treatment. The diagnosis is made by a haematologist or a ...

In their comprehensive paper in this journal on clonal diversity in the myelodysplastic syndromes, Walter et al 1 often used the term myelodysplasia to characterize patients, a broad designation ...

Practical Management of Immune-Related Adverse Events from Immune Checkpoint Protein Antibodies for the Oncologist Although chronic myelogenous leukemia (CML) is rare, with approximately 5000 new ...

A few years ago in the United States, for example, around 4,600 new cases of chronic myeloid leukemia were diagnosed. This was among 33,400 new cases of leukemias of all types. Thus chronic myeloid ...

Phase II Study of Vandetanib or Placebo in Small-Cell Lung Cancer Patients After Complete or Partial Response to Induction Chemotherapy With or Without Radiation Therapy: National Cancer Institute of ...